Drug Search Results
Using advanced filters...
Advanced Search [+]

Naftidrofuryl

Alternative Names: naftidrofuryl
Latest Update: 2023-10-01
Latest Update Note: PubMed Publication

Product Description

Mechanisms of Action: N/A

Novel Mechanism: No

Modality: Small Molecule

Route of Administration: N/A

FDA Designation: None *

Approval Status: Not Approved

Approved Countries: Algeria | Austria | Bangladesh | Belgium | Bulgaria | Cyprus | Czech | Egypt | Estonia | France | Germany | Greece | Hong Kong | Hungary | Indonesia | Ireland | Italy | Jordan | Korea | Latvia | Lebanon | Lithuania | Morocco | Peru | Portugal | Russia | Singapore | Slovakia | Tunisia | United Kingdom | Venezuela | Vietnam

Approved Indications: None

Known Adverse Events: None

Company: None
Company Location:
Company CEO:
Additional Commercial Interests: None

Clinical Description

Countries in Clinic:

Active Clinical Trial Count:

Highest Development Phases

Trial

Phase

Trial Status

Disease

Primary Completion Date

Probability of Success

Recent News Events